Johnson & Johnson to Acquire Auris Health for its Monarch Technology for $5.7B
Shots:
- J&J acquires Auris Health- in allstock transaction for $5.7B as total deal value- including $3.4B upfront in cash and $2.35B milestones. The transaction is expected to close in Q2’19
- The focus of the agreement is to advance surgical treatments in connection with digital technologies for the treatment of lung cancer including open- laparoscopic- robotic and endoluminal surgeries
- Auris Health’s Monarch Platform is an endoscopic robotic technology with advancement in micro-instrumentation- sensing- & data science in one platform for improved outcomes
Ref: J&J | Image: Twitter
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com